Learn about the latest legislative, payment and reimbursement, regulatory, legal, quality and association news in our weekly member-only news updates. Also please see these these instructions to ensure you receive IHCA member emails.

The IHCA Executive Update is sponsored by Dorsey and Consonus Pharmacy.

     

Brenda Irlbeck named IHCA’s vice president of quality improvement and clinical affairs

IHCA is excited to announce Brenda Irlbeck, RN, BSN, MBA, MSN, as its new vice president of quality improvement and clinical affairs, starting next Monday, April 12.

Brenda’s nearly 20 years of experience in long-term care regulatory compliance, clinical quality outcomes and leadership will make her a great resource to IHCA members.

She has served as the director of nursing at Edgewater, Ramsey Village and ManorCare of West Des Moines, was the director of quality management at Select Specialty Hospital and a nurse consultant with LTC Resources, Inc., in addition to serving as an adjunct faculty member at Mercy College of Health Sciences.

Brenda holds a Master of Science degree in nursing with a leadership emphasis and Master of Business Administration degree from Grand Canyon University, a Bachelor of Science degree in nursing from the University of Iowa, an associate degree in nursing from Des Moines Area Community College (DMACC) and became a licensed practical nurse through DMACC.

Additionally, Brenda is an APIC-certified infection preventionist, a 2020 graduate of the IHCA Leadership Academy and has been a member of the IHCA Quality Committee since 2017.

Brenda will assist IHCA, ICAL and ICHC members in navigating and resolving complex and timely issues with quality improvement and clinical practices and will develop and coordinate programs and systems to monitor, evaluate and improve clinical services, patient care and regulatory compliance in member facilities. Brenda will also serve as the staff liaison for the IHCA and ICAL Quality Improvement committees, as well as represent IHCA on various internal and external task forces and committees dealing with clinical, quality or regulatory issues.